Abstract：Objective: To observe the efficacy of salbutamol combined with ipratropium bromide in treatment of chronic obstructive pulmonary disease (COPD). Methods: 128 patients with COPD were individed into two groups randomly, patients in observation group (n=64) were given salbutamol aerosol joint isopropyl bromide aerosol on the basis of conventional treatment, and patients in control group (n=64) were given salbutamol aerosol on the basis of conventional treatment, two groups'clinical curative effect after 2 period of treatment were compared. Results: The total effective rate of observation group was 96.9%, significantly different compared with the control group (P<0.05); The level of VC, FEV1,FEV1/FVC,PEER and PaO2 were significantly higher than the control group (P<0.05),and PaCO2 was significantly lower than the control group (P < 0.05) after treatment; The Borg score of observation group was better than the control group (P＜0.05). Conclusions: Salbutamol combined with ipratropium bromide has a good efficacy in chronic obstructive pulmonary disease. And it is worthy to have a clinical promotion.
王春畅, 靳杨, 杨翠, 李颖, 赵亚光, 赵十妹. 沙丁胺醇联合异丙托溴铵对慢性阻塞性肺病患者的疗效及Borg评分的影响[J]. 河北医学, 2017, 23(4): 544-546.
WANG Chunchang, JIN Yang, YANG Cui, et al. Efficacy and Influence of Salbutamol Combined with Ipratropium Bromide in Treatment of COPD and Borg Score. 河北医学, 2017, 23(4): 544-546.
[1] Wen F Q, He B. Interpretation of Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (GOLD) (revised 2011)[J].Zhonghua Yi Xue Za Zhi, 2012, 92(14):937. [2] 蔡柏蔷,CAIBai-qiang.2010年慢性阻塞性肺疾病的研究进展[J].中华结核和呼吸杂志,2011,34(4):294~298. [3] 吴饶仙,况九龙.慢性阻塞性肺疾病临床表型的研究进展[J].解放军医学杂志,2013,38(6):519~523. [4] 郑爱英.孟鲁司特钠联合细辛脑注射液治疗小儿毛细支气管炎前后髓系抑制细胞、IL-12、IL-10水平变化分析[J].国际呼吸杂志,2014,34(22):1703~1706. [5] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)(一)[J].全科医学临床与教育,2013,36(6):255~264. [6] 陈遂华.呼吸困难护理综合评分和儿童呼吸困难评分在中重度支气管哮喘患儿护理干预中的应用对比[J].黑龙江医学,2016,40(4):360~363. [7] 钟南山.慢性阻塞性肺疾病在中国[J].中国实用内科杂志,2011,31(5):321~322. [8] Postma D S, Sterk P J. Chronic obstructive pulmonary disease phenotypes: current rather than future perspectives[J].American Journal of Respiratory & Critical Care Medicine, 2012, 185(5):589~590. [9] 李德鹏.综合干预对改善矽肺合并慢性阻塞性肺疾病患者心理状态和生活质量的效果评价[J].河北医学,2016,22(3):484~485. [10] 杨琪炜.沙丁胺醇联合布地奈德雾化吸入治疗支气管哮喘急性发作的疗效观察[J].河北医药,2013,35(8):1147~1148. [11] 苏秦,邓益斌,于旭旭,等.布地奈德联合复方异丙托溴铵雾化吸入治疗毛细支气管炎的临床研究[J].四川医学,2013,34(1):77~79.
2017, Vol. 23 
冀公网安备13080202000677号